Biostage, Inc.
BSTG · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $63 | $63 | $58 |
| - Cash | $1 | $1 | $2 | $2 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $62 | $61 | $56 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$2 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$2 | -$2 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.1 | -0.11 | -0.1 | -0.07 |
| % Growth | 9.1% | -10% | -42.9% | – |
| Operating Cash Flow | -$1 | -$1 | -$1 | $3 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$1 | -$1 | $3 |